መነሻ › ሶፍት ቲሹ ሳርኮማ › Pennsylvania
በPennsylvania ለሶፍት ቲሹ ሳርኮማ የሚደረጉ ክሊኒካዊ ጥናቶች
ለሶፍት ቲሹ ሳርኮማ የሚደረጉ 15 ጥናቶች በPennsylvania ባሉ ቦታዎች ተሳታፊዎችን እየፈለጉ ነው።
በPennsylvania ውስጥ ያሉ ከተሞች
Official study text (English)
Distance-Based Exercise to Preserve Function and Prevent Disability
- UPMC Hillman Cancer Center at Butler Health System, Butler
- IRMC Cancer Center, Indiana
- UPMC Hillman Cancer Center - New Castle, New Castle
- እና 2 ተጨማሪ
ተሳታዮችን በመፈለግ ላይ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Lehigh Valley Hospital - Muhlenberg, Bethlehem
- Geisinger Medical Center, Danville
- እና 7 ተጨማሪ
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ ከ40 እስከ 75 · ሁሉም ጾታዎች · የተሻሻለው በ2 ኦክቶ 2026 · NCT05334069DESTINY-PANTUMOUR04
- Research Site, Philadelphia
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
እድሜ ከ18 እስከ 130 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT07124000A Study of Repotrectinib in Pediatric and Young Adult Subjects Harboring ALK, ROS1, OR NTRK1-3 Alterations
- Children's Hospital of Philadelphia-Center for Childhood Cancer Research, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እስከ እድሜ 25 · ሁሉም ጾታዎች · የተሻሻለው በ25 ሴፕቴ 2026 · NCT04094610Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- Children's Hospital of Philadelphia- Center for Childhood Cancer Research, Philadelphia
- University of Pennsylvania Abramson Cancer Center, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ12 እስከ 85 · ሁሉም ጾታዎች · የተሻሻለው በ8 ሴፕቴ 2026 · NCT03715933Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
- UPMC Hillman Cancer Center, Pittsburgh
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ4 ሴፕቴ 2026 · NCT05711615Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- Children's Hospital of Philadelphia, Philadelphia
- University of Pennsylvania, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 1
እድሜ ከ5 እስከ 40 · ሁሉም ጾታዎች · የተሻሻለው በ3 ሴፕቴ 2026 · NCT06156410A Study to Investigate Efficacy & Safety of Intratumoral INT230-6 Compared to US Standard of Care in Adults With Soft Tissue Sarcomas (INVINCIBLE-3)
- University of Pennsylvania - Abramson Cancer Center, Philadelphia
- Temple University - Fox Chase Cancer Center, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 3
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ11 ኦገስ 2026 · NCT06263231Lead-212 PSV359 Therapy for Patients With Solid Tumors
- University of Pittsburgh Medical Center, Pittsburgh
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ18 እስከ 90 · ሁሉም ጾታዎች · የተሻሻለው በ6 ጁላይ 2026 · NCT06710756Synovial Sarcoma Registry / Biospecimen Repository
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናት
ለሁሉም እድሜ · ሁሉም ጾታዎች · የተሻሻለው በ9 ጁን 2026 · NCT05910307Application of Contrast-enhanced Ultrasound in Monitoring Soft Tissue Sarcoma Response to Neoadjuvant Radiotherapy
- Thomas Jefferson University Hospital, Philadelphia
ተሳታዮችን በመፈለግ ላይየመጀመሪያ ደረጃ 1
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ14 ኤፕሪ 2026 · NCT07436364Fluorescent Intra-operative Tumor Margin Examination
- UPMC-Shadyside Hospital, Pittsburgh
ተሳታዮችን በመፈለግ ላይደረጃ 2
እድሜ ከ18 እስከ 100 · ሁሉም ጾታዎች · የተሻሻለው በ20 ፌብሩ 2026 · NCT04719156Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Children's Hospital of Philadelphia, Philadelphia
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ ከ2 እስከ 30 · ሁሉም ጾታዎች · የተሻሻለው በ3 ፌብሩ 2026 · NCT05734066A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- University of Pittsburgh Medical Center, Pittsburgh
ተሳታዮችን በመፈለግ ላይደረጃ 1/2
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ8 ኦክቶ 2025 · NCT04370587Genomic Risk in Retroperitoneal Sarcoma
- Fox Chase Cancer Center, Philadelphia
ተሳታዮችን በመፈለግ ላይየመመልከት ጥናትጤናማ ተሳታዮች ይቀበላሉ
እድሜ 18 እና ከዚያ በላይ · ሁሉም ጾታዎች · የተሻሻለው በ31 ሜይ 2024 · NCT06436846ከ ClinicalTrials.gov የተገኘ መረጃ፣ በ5 ኦክቶ 2026 የተሰብሰቡ። እያንዳንዱ ጥናት የራሱን ቅድመ ሁኔታ ይወስናል፤ የጥናት ቡድኑ ማን መሳተፍ እንደሚችል ይወስናል።